NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine -

Five Star Friday – Reuters Health, Wall Street Journal, get top grades

5 stars 410 x 273Just a quick note, but we want to draw attention to the fact that we published three top-rated five-star story reviews this week.  They were:

  • Reuters Health’s “An aspirin a day – for years – may keep colon cancer away.” Excerpt of our review: “A strong story that describes in clear terms the findings as well as the strengths and weaknesses of this study. It covered potential biases that could not be controlled, mentioned harms, and was overall very cautious.”
  • The Wall Street Journal’s “Heart Drug Linked to Extra Years for Cancer Patients.” Excerpt from our review: “This Wall Street Journal article nicely summarizes the findings of a retrospective study of 1,400 cases of women with ovarian cancer; some of whom had been prescribed beta-blockers for high blood pressure and appeared to have better outcomes than those not taking beta-blockers. It hits on nearly all of our criteria, and was more thorough and balanced than an MD Anderson news release that initially announced the findings to the world.”
  • A story, “Should you take Tylenol, Advil, or aspirin for pain? Here’s what the evidence says.” Excerpt of our review:

    “In this installment of “Dear Julia,” Vox health reporter Julia Belluz takes on a reader question about pain medications. The reader wants to know which over-the-counter (OTC) pain reliever is the best for treating pain – Tylenol, Advil or aspirin. The story presents evidence from high-quality studies and opinions from three pain experts. The story carefully explains that it’s not appropriate to state unequivocally that one beats the other because it’s not a one-size-fits all situation. In general, though, ibuprofen (name brand Advil) is more effective and safer than acetaminophen (Tylenol) and aspirin in beating minor pain.

    The “Dear Julia” column, which debuted earlier this month, promises to answer “everyday health questions on anything from the science of hangovers to the mysteries of back pain.” The column is off to an auspicious start, and we look forward to more of its practical, evidence-based responses.”

You might also like


Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

Comments are closed.